Evaluation of Bioavailability of Phenolic Compounds From Oxxynea®
Launched by FYTEXIA · Feb 7, 2018
Trial Information
Current as of April 26, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • In good general health
- • Agreement to adhere to diet considerations
- Exclusion Criteria:
- • Smoking
- • Pregnancy / Lactation
- • Current use of any medication or food supplement
- • Known allergic reaction to components of the supplement/placebo
About Fytexia
Fytexia is a pioneering research and development company dedicated to the creation of innovative health solutions through the exploration of natural ingredients. With a strong focus on clinical trials and scientific validation, Fytexia harnesses cutting-edge methodologies to assess the efficacy and safety of its products, aimed at enhancing well-being across various health domains. The company is committed to advancing nutritional science and improving public health outcomes through rigorous research and collaboration with healthcare professionals and academic institutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Murcia, , Spain
Patients applied
Trial Officials
Pedro E Alcaraz Ramon
Principal Investigator
UCAM (Universidad Catolica San Antonio de Murcia)
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials